ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001333.1|BE-54017_1 # 1 # 693 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.698	BGC0001333.1|BE-54017_1 	1	693	-	Loose	450	25.0238	CVI-1	29.85	3006924	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CVI beta-lactamase	ATGACGCAGACAGGTCAGACCGACGAGTCCCGCGGGTTCGAGGACCCGGAGTACTGGAACTTCATGTACGACGAGGGAACCGCTCCGTGGCTCATCGGCGGGCCACAACCCGCGATCGTCGAACTGGAGGCCGCCGGTCTCGTCCGCGGCCGGGTCCTCGAACCCGGCTGCGGCTCCGGTGAGCACACCATCCTGTTCACCAGGCTGGGCTACGAGTCCCTCGGAGTCGACCTGTCGCCGAGCGCCATCGACTACGCCCGCCGCACCGCCACCGAACGAGGCGTGCCCGCGGCCCGCTTCGAGGTGGCCAACATGCTCCACCCGGAACACCACCCGTTCCTCGCGGGCGGCTTCGACACCGTCGTCGACGTGGCCCTCTTCCACGGCTTCGGCGCCTACGGGGATCCCGGCGCGGCCAAGGCCTACGCCGACGTCCTGCACGCGCTGACCAACCCCGGAGCGCTGGTGCACATCCTCGCCCACTCCGACGCGGCACCGGGCCTGAGCTCCAGCATCAGCGACGACGTCATCCGCGAGACCTTCACCGGCGGCTGGGAGGTCGAGAGCATCGAAGCAGCCCACTACCAGGGTTTCATCACGGAGCAGATCTCCGAGGTGGCCGTCCAGCGAGGACTCCCCGCCCACGGCGAGGTACAGCTCGCGGCGTGGCTGGGCCGGGTTCGCCGGCTCTGA	MTQTGQTDESRGFEDPEYWNFMYDEGTAPWLIGGPQPAIVELEAAGLVRGRVLEPGCGSGEHTILFTRLGYESLGVDLSPSAIDYARRTATERGVPAARFEVANMLHPEHHPFLAGGFDTVVDVALFHGFGAYGDPGAAKAYADVLHALTNPGALVHILAHSDAAPGLSSSISDDVIRETFTGGWEVESIEAAHYQGFITEQISEVAVQRGLPAHGEVQLAAWLGRVRRL	MRTVFGFAGALLGLAAAACAAQGGLALKHLKGGVYVVEDGYYAKENSVVYVGAEHVTVVGATWTPDTARELARQIRAVTYKPIAEVVNPNYHPDRAGGNAYWKSIGARIVSTRQTADEMRRGWDEVVAFTRRGFPDYPALPVSLPDREHPGDFELQDGRIKAFHLGAAHTRDGIFIHFPQERVLYGNCILKQELGNLSYADLNEYPKTLERLKLSELDFDTVIAGHLDALHGPELIDHYQRLLKRQASDAAAERS	90.20	gnl|BL_ORD_ID|3506|hsp_num:0	4575			105	294	
BGC0001333.1|BE-54017_2 # 802 # 2403 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.710	BGC0001333.1|BE-54017_2 	802	2403	-	Loose	600	184.882	Streptomyces venezuelae rox	33.33	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGCGCGACGAACGCGACTGCGACGTCCTGGTGGTGGGTGCGGGGCCGACCGGCCTGTGCACCGCGCTGATGCTCACGCAACACGGAGTGCGCGTGCGGATCGTCGACTCCAAGTCCGGTCCCGTCGAACAGGCACGCGCCGCCATCGTGCACGCCCGCACGCTGGAGCTCTTCGACCGGCTCGGCGTCGCGGAGGCCGCGGTCGCACGAGGCCTGCCGATCACCGACGTCGCCATCCACGAGGCCGGCCGGCACGTGGGGGACATGCCGCTCGCGGGAGAGGGCACCGGCGACCGGACGCGTTTCCCCTATGCCCTCGCGCTCGAACAGTTCGAGACCGAGCGGGTGCTGGTGGAGGCTTTGAAAGAACACCACGTCGAGGTCGAGTGGAACACCGCGGTCGTGGAGCTGGCCGACACCGGCGCGCTCGTCGGCGTCACCACCGCGGAGGGCCGGTCGATCACCGCGCGCTGGCTGGTCGGCGCCGACGGGGCGAGCAGCGCGGTGCGCGGGTTCGTCGGCCAGTCGTTCGACGGTGAGACCTACGACCAGGCGGGCATGCTGGCGGACGTCACCCTGGACGTCGACCTCGGCGTGCGCGGTATGCGTCTCAACCTGACCCGCGGCGGGTTCGTCGGAATCCTGCCGCTGGCGTCCGGCCGCTGCCGGCTCTTCGGCGTGGTGCCGAGGGAACTGGAGCAGGCCCCGTCCCAGAAGAACCCGTCGCACGAGGCCTACGCACCCTTGGCGCCCGCTGACCTGCAGAAGTGGTTCGACGGCTACTTCAAGGTGGACGCCCGGTTGGAGGAGGTCGTCTGGGCGTCGATGTTCCGCTTCCACAGCCGGATCGCCTCGCGGTTCCGCGTGGGCAACGTTTTCCTCGCGGGCGACGCCGCACACATCCACAACCCGGCCGGCGGCCAGGGTCTCAACCTCGGCGTCGGTGACGCGGTCAACCTCGCCTGGAAACTGGCGCAGGTGGTGAACGGTGAAGCGCCCGAGCGGCTGCTCGACACCTACGAGTCAGAACGCCGCCCGATCGCCCGCACCGTGCTCAAGCGCACCGACCTGGGCTTCAAGCTGGAGACCGGGAACAGCGCCGTGGCGGTCTGGATGCGCGCTCACGTCGCGACCCGCGTCGTCGGTGCGGTGTCCCGGCTCGCCCCGATCCGCCGGATGTTCTTCCACATGTTCTCCCAGCTGTGGATCAGGTACCGCAACTCGCCCGCGGTCGGCCCCGGCACCGGTCCGCTCAGGCCGGGTGACCGGGCGCCGTACGCCGAGATCAGGCCGACCCGCGACGGCGCGAGCAGCGTGCTGGACCTGACCCACGGCTCCGGCTACCACGTCCTGCTGTTCGGAGCCCAGTCGCTCGACACCGACCGGCTCGCCGCGAGCCTCGACGACCGCTACACCGTGGCGATCACCACCCACGTGATCCCACCGGAAGAGGAAGCCGCCCACCGCGCGTACCAGGTGAGCGGTCCGCTGCTGGTGCTGGTCCGCCCGGACGGCCACGTCGCCGCGGTGGCGGAACCCAAGTCGCCGGGCGTCACCGACTTCCTGGACACCGTCCTGACCCGCGTGAAGGCACCCGCCTGA	MRDERDCDVLVVGAGPTGLCTALMLTQHGVRVRIVDSKSGPVEQARAAIVHARTLELFDRLGVAEAAVARGLPITDVAIHEAGRHVGDMPLAGEGTGDRTRFPYALALEQFETERVLVEALKEHHVEVEWNTAVVELADTGALVGVTTAEGRSITARWLVGADGASSAVRGFVGQSFDGETYDQAGMLADVTLDVDLGVRGMRLNLTRGGFVGILPLASGRCRLFGVVPRELEQAPSQKNPSHEAYAPLAPADLQKWFDGYFKVDARLEEVVWASMFRFHSRIASRFRVGNVFLAGDAAHIHNPAGGQGLNLGVGDAVNLAWKLAQVVNGEAPERLLDTYESERRPIARTVLKRTDLGFKLETGNSAVAVWMRAHVATRVVGAVSRLAPIRRMFFHMFSQLWIRYRNSPAVGPGTGPLRPGDRAPYAEIRPTRDGASSVLDLTHGSGYHVLLFGAQSLDTDRLAASLDDRYTVAITTHVIPPEEEAAHRAYQVSGPLLVLVRPDGHVAAVAEPKSPGVTDFLDTVLTRVKAPA	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	111.97	gnl|BL_ORD_ID|4833|hsp_num:0	5820			6	1392	rifampin; rifaximin; rifapentine
BGC0001333.1|BE-54017_3 # 2608 # 3303 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.703	BGC0001333.1|BE-54017_3 	2608	3303	+	Loose	556	29.6462	erm(32)	26.0	3004592	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAGTACCGCACCGGAAGCGTTTTTCGACGACCTGGCCGAACTGTACGAGCGCTTCACGCTCATCCGCGACGCCGCCACGAGTCCGGTGCGGTCGTGGCTCGTCGAGCAGTTGCCCGCCGGTTCCCGCGCACTCGACGCCGGCTGCGGCAGCGGCAACAACTGCGGCATGCTCGCCGAGCGGTACGACGACGTGGTCGGCGTCGACGTGTCGCGGAAGATGCTCGACATCGCGGCCACGAAGCGGACGCGGGTGCCGGTGCGGTACGAGTGCCGCGACGCCGTCGACCTGACGCCCGAGCGGGACGGCCGCTTCGACCTCGTGATGTCGGTCAACGCCGTGTTCCACATGGGACCCGCGGACGAGGTGCTGCCCGTGCTGCGCGCCCTCGTCGCTCCCGGCGGCAGGCTGGTGGTCGTCGACGTGACGCAGCCCGACGACGCGGCGGCCCCCGCCGAGCAGAGCGCTTACGCGTTCCAGACCGGCAAGATCATCTACGACGTCTCCCGCGACGTCGAGGCCGCGTGCGACTCGATCCGGATGATGCTGCACCCGCGCTGGCTCGAGATGAGCGCCGCCGCGATGCCCCTCACCGACTCGGAGTTCCGGTCCCAGTACGAGCGGGCGCTGCCCGGCGTGCGGATCACCAGGGACCTCATCCCCACGATGAGCGCGGCCGTCTGGGACAACGCATGA	MSTAPEAFFDDLAELYERFTLIRDAATSPVRSWLVEQLPAGSRALDAGCGSGNNCGMLAERYDDVVGVDVSRKMLDIAATKRTRVPVRYECRDAVDLTPERDGRFDLVMSVNAVFHMGPADEVLPVLRALVAPGGRLVVVDVTQPDDAAAPAEQSAYAFQTGKIIYDVSRDVEAACDSIRMMLHPRWLEMSAAAMPLTDSEFRSQYERALPGVRITRDLIPTMSAAVWDNA	MRKNVVRYLRCPHCAAPLRSSDRTLRCENGHTFDVARQGYVNLLRRPTKLAADTTDMVAARAALLDSGHYAPLTERLAGTARRAAGAGAPDCVVDIGGGTGHHLARVLEEFEDAEGLLLDMSKPAVRRAARAHPRASSAVADVWDTLPLRDGAAAMALNVFAPRNPPEIRRILRPGGTLLVVTPQQDHLAELVDALGLLRVRDHKEGRLAEQLAPHFEAVGQERLRTTLRLDHDALGRVVAMGPSSWHQDPDELARRIAELPGIHEVTLSVTFTVCRPLP	82.50	gnl|BL_ORD_ID|2699|hsp_num:0	3294			279	558	narbomycin; methymycin; pikromycin
BGC0001333.1|BE-54017_4 # 3300 # 6347 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.690	BGC0001333.1|BE-54017_4 	3300	6347	+	Loose	300	27.335	dfrA23	24.66	3003019	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGAGCGTCTTCCACCTCCCCCGCCTGCACTTCGCGGGCACGGCCATCACCCGCCTGCCCACCGGGCCGCGCGCGGGCTGGCTCGACCTCGAGACCAACCAGGCCATCGACGACCAGGGCGTGTTCGACACCGACCGCCCCGTCCAGGAGTACTACGACTTCCTCGCGGACGCCAAGGGCCACAACTTCGAGGGCAACGGCCACTTCTGGGTCGACGCGAAGGTCGTGGCCACCGAACTCGCTCCGGGCGAGGTGCGCTCCGACGACCTGGTGACGGGACGGCAGCTCGATCTCTGGGGTCACTTCTGCGACTACACCGCGGGCACCGCCAACCGGTCGCGCGTGTTCGACGTCGACCCGGCCTCCAACTGGACCACGACGCTGATGGTCGGCCAGCTCGCGCTCGGCAGGTCGGGCCGCTCGCACGACGTGCCCTACCTCGTCACCGGTGACGTCAACGGCATGTGCCCGCCTCGCTGGAACCAGTTCCACACCGTGCTGCACCAGTTCGCCGTCGACAAGGCCGAGGGGCTGCATTGGCTCAGCGGTGTCGCGGACTCCCCCGTGCTCACACGGCTGCGCGAGGTGGTCGAGAACGACGCGGACGGCCTGGTGGTCCAGTTCGCGCTCAGCGACCAGAAGCACACGGGCGAGGGCCAGCCCGACGTCTGGCAGCTGCGCGGGACCGTCGCGGCCTGGTACCGCGACGAGCTGCGCAGCTACCCGGCCGGGCGGCTGCTCACACCGCGCACCACGCGTTCCGCGTTGCACAACCTCTCCGTGCACGTCAGCGACGACCACGTCACCGCGAACCTCGTCACCGCGCACCCGGACACCGACCTGGAGGTGCGCACGGCCTGCGGCACGCTGCTCGCGACCATTCCGTCCACAACGGACTCGCGCACGTCGGGCGTCGTCGTGGCGGCACGGGTGGACGGTGCGACCGGCAACCCGGCCGAGGCGCTGGTGATCACCGACGGCGAAGGAACCGTGCTGTCGCGCGAGGAGGAGACCGTCATCGAGTCCGACGAGGCCGCGTTGTTCCTGGAGCACGAGAACACCAGGACCGGCGAGGACCACGCCGTCGAGATCCCCGTCCGCTCCTACCTGCGCGGTGTCCCCGCGCGGGTCGACCAGGTCCACGTCCGGCAGTACGTGAACCCCGCCGCTCTGCCACTCGCAGGCGACCGCGACAGCGCTCAGCTCGTCGCGTTCCTGCCCACCGGACAAGCCGGCTACCAGGCCGAACAGGTGCTCTCGACCGACGAGCACGGCCGCGGCGCCATCACGCTCAAGGGTGTGCGGGGCGGCGCGACGAGGGTCCTGCTCCGGCCGGAGCCCACGCCGGAACCGCGGGGCACCACGGCGGCCGAGCGCTACGACAACGACGACGAGCAGGGCTACTGGTCGGCGGTCGGCTCCATCGCGGTGCGGGTGCTGCCGAACCACTGGCACCTCGACGACCTGCCGGACGAGGACATCACGTTCAGCACGGTGTACCGCGAAGCGCTCGCCTACTACGAACTCCAGTACTCGTTCATGCGGTCCGAGGTGCTGAGCCTCGCCGACGAGTTCAAGGTCGAGCCTTACGCCCGCCTCATCTGGCACGTGTCCGCGCCCGAGCACAAGGGCAGGACGTTCTACATGCCCCCGACGCGCGACATGAGCGCACCGCAGATCCGGATGTTGCTGCGCTACCTGCTCGCCGACGACGCCCAACGGCAGACTCCGCCGACTTTCGTTCCACAGCAACGAAAACTCGGCACGATCACGACGAAGGACCAGCTGCTGCACGCGCTCTACCAGGCAGCGGCGATCGAGCTGGCCACCATGGTGCAGTACCTGTACGCGGCCTACAGCGTGCCGACCCACGGCGCCGGCAGGAAGCTCGTCCAGCGCGGCGAGTGGACCGAGGAGCAGCTGCTCACGGCGTGCGGTGAGGGCACCGAGACCTGGAGCAACGGCATCCGCGGCAGTCTGATGTCCGTCGCCCGCGAGGAGATGATGCACTTCCTCGCGATCAACAACATCCTGATGGCGATGGGCCGGCCGTTCCACCTGCCCAAGCTCGACTTCGGCACGTTCAACAGCACCACCTGCGTCCCACTGGAGTTCTCGCTCGAGGCGCTGAACCTGGCGAGCGTGCAACGGTTCGTGGCGCTGGAACAGCCGCACGACCTGATCGAGGAGATCGAGGGCAACGACTCCACGGTCCTGCGCGCGGACGGGGAGCCGTACCAGTACGGGTCGCTGAGCGAGCTGTACGCGGCGATCCGCGAGGGCGTTCAGGCCGTGCCGGGCGTGTTCCTGGTGAAGAAGGGCCGCGGCGGTGGCGCCCACCACCTGTTCATGCGCGAGTCCGTCAACGCCGTGCACCCCGACTACCAGCTCGAGGTCGACGACGTGGCGAGCGCGGTGTTCGCCATCGACTTCGTCACCGAGCACGGCGAGGGCGGCCAGATCCCCTCGACGCTGCCGGAGGAGGAGTCGCACTTCGACACGTTCCTGCGCATCTCCGAGATGCTCATCGCCGAACGGGCGAAGGGCCCGAACGACCGCAGGGTGCCGTGGAACCCCGCCTACCCGGTCATGCGCAACCCGACGCTCAAGCCGGGCAACGCCGCGATGGACCACGTGACGCACGAACCGGCCCGGATCGCCATGAAGGCGTTCAACCGCTCGTACTTCATGGCGATGCAGCTGATGGTGCAGCACTTCGGCTACAGCCCCGACAAGTCGTTGCGCCGCAGCCGGTTGATGAACTGGTCGCTGGACGTCATGACCGGCGTGCTGCGGCCGCTCGGCGAGCTGATCGTCACGCTGCCGTCCGGACGGCCCGGCCGCACCGCGGGCCCGTCGTTCGAGCTCGACTCCGGCCCGGAGTACATCTCCCGGCCCGACGTCGCGGTCGAGTGGATGGCCCGCGAGTTCGACGAGGTGGCTGATCTGGCCCGCAAGTGCGTCGGCTTCGGCCTCACCCCGACCGTGGGCGACCTGCTGGCCTTCATCGGTGACTCGTTGCGCACCATGGACCTGAAAGACCTCTGA	MSVFHLPRLHFAGTAITRLPTGPRAGWLDLETNQAIDDQGVFDTDRPVQEYYDFLADAKGHNFEGNGHFWVDAKVVATELAPGEVRSDDLVTGRQLDLWGHFCDYTAGTANRSRVFDVDPASNWTTTLMVGQLALGRSGRSHDVPYLVTGDVNGMCPPRWNQFHTVLHQFAVDKAEGLHWLSGVADSPVLTRLREVVENDADGLVVQFALSDQKHTGEGQPDVWQLRGTVAAWYRDELRSYPAGRLLTPRTTRSALHNLSVHVSDDHVTANLVTAHPDTDLEVRTACGTLLATIPSTTDSRTSGVVVAARVDGATGNPAEALVITDGEGTVLSREEETVIESDEAALFLEHENTRTGEDHAVEIPVRSYLRGVPARVDQVHVRQYVNPAALPLAGDRDSAQLVAFLPTGQAGYQAEQVLSTDEHGRGAITLKGVRGGATRVLLRPEPTPEPRGTTAAERYDNDDEQGYWSAVGSIAVRVLPNHWHLDDLPDEDITFSTVYREALAYYELQYSFMRSEVLSLADEFKVEPYARLIWHVSAPEHKGRTFYMPPTRDMSAPQIRMLLRYLLADDAQRQTPPTFVPQQRKLGTITTKDQLLHALYQAAAIELATMVQYLYAAYSVPTHGAGRKLVQRGEWTEEQLLTACGEGTETWSNGIRGSLMSVAREEMMHFLAINNILMAMGRPFHLPKLDFGTFNSTTCVPLEFSLEALNLASVQRFVALEQPHDLIEEIEGNDSTVLRADGEPYQYGSLSELYAAIREGVQAVPGVFLVKKGRGGGAHHLFMRESVNAVHPDYQLEVDDVASAVFAIDFVTEHGEGGQIPSTLPEEESHFDTFLRISEMLIAERAKGPNDRRVPWNPAYPVMRNPTLKPGNAAMDHVTHEPARIAMKAFNRSYFMAMQLMVQHFGYSPDKSLRRSRLMNWSLDVMTGVLRPLGELIVTLPSGRPGRTAGPSFELDSGPEYISRPDVAVEWMAREFDEVADLARKCVGFGLTPTVGDLLAFIGDSLRTMDLKDL	MPTVEIIVAVDPVGGFGRNGQIPWTCKEDMKRFTTISKEIRVCVMGKNTYKDMLDMQMKKEGAEERIKEKGILPERESYVVSSTLKPEDVIGATVVPDLRAVLNQYHDSDQRIAVIGGEKLYVQALASATKVHMTVMHKPYNCDRTLPMSYIDKKFVAGQGSITIQTAVDGETHPVKFITYERARP	545.70	gnl|BL_ORD_ID|721|hsp_num:0	787			18	450	trimethoprim
BGC0001333.1|BE-54017_5 # 6347 # 7588 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.696	BGC0001333.1|BE-54017_5 	6347	7588	+	Loose	600	63.5438	Streptomyces venezuelae rox	26.27	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGACTGAGAAGACGACAGTGTGCATCGCGGGCGGCGGCCCGGCCGGTGCCGTGCTCGGGCTGCTGCTGGCGCGTTCCGGGGTGGACGTCGTGGTGCTGGAGAAGCACGCCGACTTCCGCCGCGACTTCCGCGGCGACACCGTGCACCCGGCGACCCTGCAGATCCTCGACGAGCTCGGGCTCATCGAGAAGTTCCACGCGCTGCCCCACCAGAAGGTCAGCACGATCGGCGTCGTGCAGGAAGGCAGGCGGATCGACATCGCCGACTTCCGCCGGTTGAAAGTCCGCTACCCGTACATGGCGTTCGTGCCGCAGTGGGACTTCCTCGACCTCATCACCGCGGAGGCGAAGAGGTATCCCGGCTTCCGCCTGCTGATGAACACCGAGGCGCTGGGCGTCGTGCGGGACGAGGGCGGACGGGTCGCCGGACTGCGCGTGCGCGGGCCGCAGGGCGAGCGGCAGATCCGGTCGACGCTCGTGGTCGCCGCCGACGGGCGGCACTCGGTGATCCGGCGGGACGCGGGGTTCGTGCCGACGCTGATCGGCCGGTCTCTCGACGTCATCTTCTTCAAGATCTCCCGCAGGGACACCGATCCCGACGAGGGCATCTGCGTGCGGATCGGCAACGGCAAGATCTTCGGCGCGACCGACCGCCGCACCTACTGGCAGATGTCGTACGAGACGTCCACCGGCGGCATGGAGAAGGTGCGGGGCGAGGGGCTCGACAAGTTCCGGGCAGACCTCTCCGAGCTGGTGCCGTTCCTCGCCGACCGGGCGCACGAGGTGTCCTCCTTGGACCAGCTGAGTCCGTTGGAGGCGCGGATCGACCGGCTGGAGCGGTGGCACGAGCCGGGCCTGCTGTTCATCGGCGACGCGGCGCACGCGATGTCCCCGGTCGCGGGGTTCGGTGTGAACCTCGCGGTGCAGGACGCCGTGGCCACCTCGAACATCCTCACCGCCGAGCTGCTGCGGGCCCAGGAGGGCCGGATCTTCGACGACGAACTGCTGGCGCGGGTCCGCCGACGCCGCAAGCGCGCGGTCGCGTTGTCGCAGGGCTTGCAGCGCGCGACCCAGAAGTTCGGCATCGACGAGGCGCTCGACGGGTCCGGTCAGCCGCCGGCGCCGAAGGTCTTCGAGAAGCTCGGCGTCGCCCAGTGGCTGATGAGCCGCGTCATCGGACTCGGGTTCCGGCCGGAACACGTTCGCACACAGGAGAAAGCGCCGGAGGGAACCGTTAGATGA	MTEKTTVCIAGGGPAGAVLGLLLARSGVDVVVLEKHADFRRDFRGDTVHPATLQILDELGLIEKFHALPHQKVSTIGVVQEGRRIDIADFRRLKVRYPYMAFVPQWDFLDLITAEAKRYPGFRLLMNTEALGVVRDEGGRVAGLRVRGPQGERQIRSTLVVAADGRHSVIRRDAGFVPTLIGRSLDVIFFKISRRDTDPDEGICVRIGNGKIFGATDRRTYWQMSYETSTGGMEKVRGEGLDKFRADLSELVPFLADRAHEVSSLDQLSPLEARIDRLERWHEPGLLFIGDAAHAMSPVAGFGVNLAVQDAVATSNILTAELLRAQEGRIFDDELLARVRRRRKRAVALSQGLQRATQKFGIDEALDGSGQPPAPKVFEKLGVAQWLMSRVIGLGFRPEHVRTQEKAPEGTVR	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	86.76	gnl|BL_ORD_ID|4833|hsp_num:0	5820			9	924	rifampin; rifaximin; rifapentine
BGC0001333.1|BE-54017_6 # 7585 # 8595 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.711	BGC0001333.1|BE-54017_6 	7585	8595	+	Loose	700	26.9498	CMY-40	41.03	3002051	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	ATGACCGCACCGGGAATGCCGCCGCAGGCACGGATGATGCAGATGATCACGGGGTACTGGATCACCCAGGTCGTGCACGCCGTCGCCGAGCTCAGGATCGCCGACCACCTCGCCGGGAACGCGCTGACCCTGGAGGAACTCGCGGCACGGACGGGCGCCGGCGCCGACACGACGCTGCGGCTGCTGCGTGCCTGCGCCTCGCAGGGACTCGTGGCCCACGACGAAGGCCGGTTCGCCAGCACGCCGTTGCTGGAGACGCTGCGCGAGGGCGTGCCGGGGTCGTTCCGCGACATCGCGATCGTGCACGGCTCACCGGGACACTGGCTGTCCTGGGGCCGGTTCCCGGACGCGGTGCGCACGGGTGAGCCGCAGACCAAGGCCGCGCTGGGCAGCGACATCTGGACGTACTTCCAGTCCCAGCCGCAGGAGTGGGAGCGGTTCTCCAACTCCATGACCGAACTGACCGACGGCCTGTCGCGCGAGATCGGCGCGCTGCTCGACACCACGGGTCTCACCACGGCGGTGGACGTCGGCGGCGCGAACGGCGCGCTGCTGCACCCGTTGCTGAAGGCGAACCCCGGTCTGCGGGGCGTGGTGTTCGACCTCCCGACCGTCGAGGCGACCGCGGTGGCCGAGGCGGAGAAGGCAGGTCTGGCCGGCCGCTGCACGTTCACCGGTGGCTCGTTCTTCGACTCGGTGCCCGAGGGCGACCTGTTCCTGCTCAAGGCCGTGCTGCACAACTGGGCAGACGAGTCGTGCGTGCAGATCCTCACCAACTGCCGCAAGGCGCTCCGCCCCGGCGGACGGGTGGTCGTCGTCGAGATGCCGCTGGGACCGCTGGGAGAACCGGGGTTCGCCCCGCTGCTCGACCTCGGGATGCTCGCCGTCAACGCGGGCCGCGAGCGCGACCTCGACCAGTACGACGCCCTGTTCCGGGCTTCCGGCCTGCGTCGCGCCGAGGTCACGCCGACCTCGTCCCCGCAGAGCCTGATCCACGCCGTAGCCGCGTAA	MTAPGMPPQARMMQMITGYWITQVVHAVAELRIADHLAGNALTLEELAARTGAGADTTLRLLRACASQGLVAHDEGRFASTPLLETLREGVPGSFRDIAIVHGSPGHWLSWGRFPDAVRTGEPQTKAALGSDIWTYFQSQPQEWERFSNSMTELTDGLSREIGALLDTTGLTTAVDVGGANGALLHPLLKANPGLRGVVFDLPTVEATAVAEAEKAGLAGRCTFTGGSFFDSVPEGDLFLLKAVLHNWADESCVQILTNCRKALRPGGRVVVVEMPLGPLGEPGFAPLLDLGMLAVNAGRERDLDQYDALFRASGLRRAEVTPTSSPQSLIHAVAA	MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGTLAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMAHWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGYTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ	88.19	gnl|BL_ORD_ID|686|hsp_num:0	745			945	1062	
BGC0001333.1|BE-54017_7 # 8621 # 10168 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGGAG/GGAGG;rbs_spacer=11-12bp;gc_cont=0.676	BGC0001333.1|BE-54017_7 	8621	10168	+	Loose	550	26.1794	APH(2'')-Ie	22.62	3002634	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(2'')	ATGTTGAAGAACGTAGTGGTGGTCGGCGGCGGAACGGCCGGCTGGATGACCGCGTCCTACCTGACAGCCGCGTTCGGCGACCGGATCGGCGTCACGCTCGTCGAGTCGAAGCGCGTCGGCTCGATCGGCGTCGGCGAGGCGACGTTCAGCACTGTCCGGCACTTCTTCGAGTACCTCGGTCTCGAGGAGAAGGAGTGGATGCCCGCCTGCAACGCCACCTACAAGCTCGCCATCCGGTTCGAGAACTGGCGCGAGCCGGGACACCACTTCTACCACCCGTTCGAGCGTCAACGGGTCGTCGACGGCTTCCCCCTGACGGACTGGTGGTTGCGCGAACCCAGGTCCGACCGGTTCGACAAGGACTGCTTCCTGGTCGGCACGCTGTGCGACGACCTGAAGTCACCGCGGCAGCTGAACGGCGAGCTGTTCGAGGGCGGCCTGGGCGGGCGCAGCGCCTACCGCACGACGCTGGCCGAGCAGACCACCCAGTTCCCCTACGCCTACCACTTCGACGCGACGCTGGTCGCGAACTACCTGCGCGACTACGCGGTCGCGCGGGGTGTGAAGCACGTCCTCGACGACGTGCAGGACGTGGCGCTAGACGACCGCGGCTGGATCAGCCACGTGGTCACCGGGGAGAGCGGGAACCTCACCGGCGACCTGTTCATCGACTGCACCGGTTTCCGCAGCCTGTTGCTGGGCAAGGCGCTCGCCGAGCCGTTCCAGTCCTACCAGGACTCCCTGCCCAACGACAGCGCGGTGGCGTTGCGCGTGCCGCAGGACATGGAGAACCGGGGACTGCGGCCGTGCACGACGGCCACCGCGCAGGAGGCCGGCTGGATCTGGACGATCCCGCTGTTCGACCGCATCGGCACCGGCTACGTCTACGCCGGCGACTACATCTCCCCGGAGGAGGCCGAACGCACGTTGCGGGCGTTCGTGGGCCCGGCCGCCGAGCACGCTGACGCGAACCACATCAAGATGCGCATCGGCCGCAGCAATCGGCACTGGGTGAACAACTGCGTGGCGGTCGGGTTGTCGAGCGGCTTCGTCGAGCCGCTGGAGTCGACCGGCATCTTCTTCATCCAGCACGCCATCGAGCAGCTGGTGAAGCACTTCCCGGACGAGCGCTGGGACGACGGACTGCGCACGGCCTACAACAAGCTCGTCAACAACGTGATGGACGGCGTGCGGGAGTTCCTCGTCGTCCACTACTACGCCGCCAAGCGCCAGGACAACCAGTACTGGAAGGACGCCAAGACCCGTCCTCTCCCCGACGGCCTGGCCGAGCGGCTGGAGCGCTGGCAGACCCGGCTGCCCGACAACGAGTCGGTCTTCCCGCACTACCACGGGTTCGAGTCCTACTCCTACGTCTGCATGCTGCTCGGCCTGGGCGGCCTCGACCTGAAGTCGTCGCCCGCGCTCGGACTGATGGACGCCGCGCCGGCCCGGCACGAGTTCAAACTCGTGGGTGAGCAGGCCGCCGAGCTCGCCCGCACGCTGCCCACGCAGTACGAGTACTTCGCCCAGCTGCACCGCGCGAGGTGA	MLKNVVVVGGGTAGWMTASYLTAAFGDRIGVTLVESKRVGSIGVGEATFSTVRHFFEYLGLEEKEWMPACNATYKLAIRFENWREPGHHFYHPFERQRVVDGFPLTDWWLREPRSDRFDKDCFLVGTLCDDLKSPRQLNGELFEGGLGGRSAYRTTLAEQTTQFPYAYHFDATLVANYLRDYAVARGVKHVLDDVQDVALDDRGWISHVVTGESGNLTGDLFIDCTGFRSLLLGKALAEPFQSYQDSLPNDSAVALRVPQDMENRGLRPCTTATAQEAGWIWTIPLFDRIGTGYVYAGDYISPEEAERTLRAFVGPAAEHADANHIKMRIGRSNRHWVNNCVAVGLSSGFVEPLESTGIFFIQHAIEQLVKHFPDERWDDGLRTAYNKLVNNVMDGVREFLVVHYYAAKRQDNQYWKDAKTRPLPDGLAERLERWQTRLPDNESVFPHYHGFESYSYVCMLLGLGGLDLKSSPALGLMDAAPARHEFKLVGEQAAELARTLPTQYEYFAQLHRAR	MTTYTFDQVEEAIEQLYPDFTINTIEISGEGNDCIAYEINGNFIFKFPKHSRASINLLNEVTVLKTIHNELSLPIPEVVFTGMPSEMCQMSFAGFTKIKGVPLTPLLLKNLPKQSQDQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGHQMKKVDDFYRDILDNEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYMMKEKYWSFEKIIYGKEYGYMDWYEEGLNEIRSIKIK	171.10	gnl|BL_ORD_ID|119|hsp_num:0	137			318	570	amikacin; kanamycin A; tobramycin; gentamicin A; gentamicin
BGC0001333.1|BE-54017_8 # 10174 # 11412 # 1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.734	BGC0001333.1|BE-54017_8 	10174	11412	+	Loose	1080	41.5874	rosB	25.14	3003049	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGGTGCTGAACGGGATGCACCTCGTCGCGCTCCTGGCCGCGTTCTTCGCGGTCGCGGCGCTCGGCCGGGTGATGGCACGGGCGCTGCGGACGCCCACCGTGATCGGTGAGATCGCGTTGAGCATCCTGCTCGGGCCGGTGCTGCTGGCCGCGTTCGGCAAGAGCCTCTTCACCGCGGTCCTGCCGGCCGACGTCACCGCTGTGCTCAAACAGATCGGCGAGGCCGGGCTGGTGCTCTTCCTCGTCGGTGTGGTGCACCACCTCGACCGCGGCGTCACGGGCGGGTGGCACGGCAAGGCGCTCGGCCGGATCACGATCGGCGCCTTCGCGCTGCCGTTGCTGACCGGTCTCGCCTTCGCCGCCTGGGCCGTCTGGCTCGCGCCCGCCGAGGTGCGCGGCACCGCTCCGACGGCCGCGCTGGTGCTGGTGCTCGCGGTGGCCATGTCCGTCACGGCGGTGCCCGTGCTCGCGCGCATCCTGGAGGAGCGGTCCGACCTGGGTCGCGCCTCCGGGCTGTCGATGATGGCGTCGGTGCTGATCGACACGCCGGCCTGGCTGTTGCTGACCGTGGCGCTGGGTCTGGCCGCGGGTGGCCTCGGTGGCGTGTGGCTCGCGTTCGCGACCATCGGCGTGGGCGTGGTGATCGCGTGGCTCGGTCGCCGGGCGCTCGGGTCGGAGCGCGTCGGGAACGTCGCGGCGGAAAGGCCGCGCACGACCGCTCTCGTCCTCGCGGTGGTGGCACTGGCCGCAGGCACGGCGGTGCATTCCCTCGGGCTCACGGCGATCTTCGGCGCGTTCCTGGCCGGCGTGGTGGTGCCGCGCGACGAGGCGTGGTCGCGGGTCGTCGCGCTGGTCAGCCGGGTGGGCAGGGCGTTCGTGCCGGTGTTCTTCGTGGTGGCGGGGACGACGCTGTCCACCAGCGGGGTGTCGGCGTTCCCGTGGATCGGCGTCGCCCTGGCGCTCGCGCTCGGCGTCCTCGGCAAGATCGGCGGCGGGTACGCCGGGGCGCGCTGGGGCGGCGAGGACGCGGTCACGTCGCTGCGGATCGGCGTGCTCGTGAACACGCGCGGGCTCACCGAGATCGTGGTGCTCCAGATCGCGTTCACCGCCGGTCTGCTCACGCCGGGGCTGTTCGTCGCGCTGCTGGTGATGGCGCTGGTGACGACCGCGCTCACGGGTCCGCTGCTGGACGTGATCACCCGGCGTGCCGGGGCGGCACGGCAGGAGGTCTTGGTGTGA	MVLNGMHLVALLAAFFAVAALGRVMARALRTPTVIGEIALSILLGPVLLAAFGKSLFTAVLPADVTAVLKQIGEAGLVLFLVGVVHHLDRGVTGGWHGKALGRITIGAFALPLLTGLAFAAWAVWLAPAEVRGTAPTAALVLVLAVAMSVTAVPVLARILEERSDLGRASGLSMMASVLIDTPAWLLLTVALGLAAGGLGGVWLAFATIGVGVVIAWLGRRALGSERVGNVAAERPRTTALVLAVVALAAGTAVHSLGLTAIFGAFLAGVVVPRDEAWSRVVALVSRVGRAFVPVFFVVAGTTLSTSGVSAFPWIGVALALALGVLGKIGGGYAGARWGGEDAVTSLRIGVLVNTRGLTEIVVLQIAFTAGLLTPGLFVALLVMALVTTALTGPLLDVITRRAGAARQEVLV	MHHSTPLITTIVGGLVLAFLLGSLAHRLRSSPLVGYLAAGVLAGPFTPGFVADTSLAPELAEIGVILLMFGVGLHFSLKDLLAVKAIAIPGAVAQIAVATLLGMGLSHLLGWDLMTGFVFGLCLSTASTVVLLRALEERQLIDSQRGQIAIGRSIVEDLAMVLTLVLLPAFAGVMGNETTSLSQLFTELAITIGKVIAFITLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAYGAVGLFDVSFALGAFFAGMVLNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILLREPLAVLASLAIIIFGKSAAAFILVRMFGHSNVYSTHHFCPWRKSVNLPFILAGLGISLGLMSEHGRNLVLAGAILSIMLNPLLFTLLDRYLAKNETMEDLILEEAVEEEKQIPGRFVQSCTVSRLWSGGSLLGAKLHAEGIPLVVIENSRPRVEALREQGINAVLGNAASADIMSLARLDCALVIILTIPNGYEAGEIVASARIKRPDLEIIARAHYDDEVVYISVRGANQVVMGEREIANSMLNMLKIETLTEEDKRPLCPI	73.18	gnl|BL_ORD_ID|466|hsp_num:0	507			69	1002	polymyxin B; polymyxin B1; polymyxin B2; polymyxin B3; polymyxin B4
BGC0001333.1|BE-54017_9 # 11409 # 11891 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.706	BGC0001333.1|BE-54017_9 	11409	11891	+	Loose	400	24.2534	EreD	28.57	3004608	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide esterase	GTGACAGAACAGTTCCGCGGGCTCATGGCCGCTTTCCCGACCGGTGTCGCCGTGGTGACGACCTTCGGTCAGGACGGTGAGCCGTGGGGGATGACGCTGTCGTCGCTGTCGAGCGTGTCGGTGGACCCGCCGACGTTGCTGGTGTGCCTGCGGTACAGCAGCCCGACGCTGGACGCGTTGGTGCGCACCGGTTCCTTCACGGTGAACCTGTTGCACCACGAGGCGCGTCCGGCCGCGGAGCTGTTCTCGTCGGGTGACCCGGACCGCTTCCGGCAGGTGGCGTGGGAACATCCCGCGTCCCTCGGCGGGCCGCACCTGGTGGACGACGCGCACGCGGCGGCGGACTGCGTGGTGGACCACATGCACCGCACCGGCACGCACGTGGTGGTGTTCGGCAAGGTCCACACGGTCGTGCACCGCTCAGCCGCCCAGCCGCTGCTCTACGGGCTGCGCCGGTACGCCTCCTGGCCGCGGAGCGCTTGA	MTEQFRGLMAAFPTGVAVVTTFGQDGEPWGMTLSSLSSVSVDPPTLLVCLRYSSPTLDALVRTGSFTVNLLHHEARPAAELFSSGDPDRFRQVAWEHPASLGGPHLVDDAHAAADCVVDHMHRTGTHVVVFGKVHTVVHRSAAQPLLYGLRRYASWPRSA	MKNIKPLTFPFNSENNTSIKQSLFRFREYFDSSTIVGLGENSHFIKEFFTFRHQVIEFLVTECDFDTLAFEFGFSEGLEVDKWIKSQIPFDDLDKLLSHFYYPNEFKDTLLWLRRYNQDNNNQITFLGVDIPKNGGSYFPNFRIVSDYLQRLSIVSSDVLQKILNLAEKFDFYSTSQLALNLSLFDEAEHNELKALLLKVYIRLVTLQPKLESLEFQSILHQVKGLIYMNYNADAMESFITEKGIEGDMGAKDQYMAESIDWFLKNSLGKKIILVAHNAHIQKTPVDFDGFISCYPMGQRLSMTFGEKYKAFAITNLRGETAALYPDNDYQFGFRVDKFPLDSPESDSVEFFMQELSGKECCLIINKSKELKNCSKIRFDSIYLKTEIVDSFDGIFLIEKSTVSEIVD	39.22	gnl|BL_ORD_ID|1193|hsp_num:0	3305			861	945	erythromycin
BGC0001333.1|BE-54017_11 # 12901 # 14442 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.718	BGC0001333.1|BE-54017_11 	12901	14442	+	Loose	800	30.4166	tet(48)	43.75	3004581	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGTGGGCGCAGGGCCGCGGCGGCACGATTCCGTTCATGAGTCCGGTGCACACGAACGTCCTCTCGGGCGGACAACACTGGCCGCAACGCCCGAAGCGGGTGACCGTCCTCGGCGCGGGCGTCGCGGGCCTGGTGGCGGCGCACGAGCTGGAACGCCTCGGCCACAGCGTCGAGGTGCTGGAGGCGCGGCTGGAGGTCGGTGGCCGGGTGCGCACGCACTCGTTCGTCGGCAGGGGCCCGCTCGCCGAGCTCGGCGCCATGCGCATCCCCGCCTCGCACCACCGAACCATGCAGTGGATCGACCTGCTGGGGCTGAGCGACAGGGTGCGGCAGTTCCGCACGCTGTTCTCCGACGACTCCAGCTACCTGGAGACCTGCACCGGGCACCTGCGGGTGCGCGACGCGACCTCGGTGCTCGTCGAGGAGTTCCGCCGCGGCCTGCCTCCCGGCGAGTACCGCGAGGAGTCCGTGCTCGCGGCGACCTGGCTGACCGCGAGCGTGAACGCCGTGGCGCCCGGCGCGTTCCGCACGAACCTGCACAGCGACCTGAACCTGGAACTGCTCGACCTGCTCGACGGCATCGACGTGCGGCCGTTCTTCGTGAGCACCGGCGGCGTCGAAAGGCTCGACGTCAACCGGTTCTTCGCGGGCAACCCGAAGTTCGCCGGGCGCAGCCGTCTCGCGCACTTCTTCGACGACATCACCGTGGAGACGTCGTCGGCGCTGTTCCGGCTCGAAGGCGGGATGGACCAGATCACCGTCAGGCTGGCCGGGAGCCTGCGCGGCCCGGTCCACCGCGGCCGCCAGGTCGTCGGGCTGCACGTACGGCCCGACGGCGTGGTGGTCGAGACGCGGCGCGGCCTGGACGTCGTCGCGAGCCACTGCGACTACGTGCTGTGCACCGTGCCGTTCTCGGTCGTGCGGAGGATGAACCTCAGCGGACTGGACGACGACAAGGTCGCGACCGTGCACGACATGCAGTACTGGCCCGCCACCAAGATCGCGGTGCACTGCCAGGACGCGTTCTGGGAGGGCGACGGCATCAGCGGCGGCGGCTCGTTCACCGGCGGCCTGGTGCGCCAGACCTACTACCCGCCGGTCGAGAGCGACCCACGGCTCGGCGCGGCCCTCCTCGCGAGCTACACGATCGGGCCGGACTCGGACGCGCTGACGCGGTTCTCGCCGCCGGAGCGGGAACGCGTCGTGCTCGACGAGCTCAGCAGGATCCACCCCGAGCTGAAGAGGCCGGGAATGGTGCTCGACGTGGTGACCCAGGCCTGGGGCGAGGACTTCTCCAGCATGGGGGCCGCGTCGGTGCGGTGGAGCAAGGACGCCGCGACGGCCGAGGAGGAACGGGCGCTGGCGGCCAAGCCGCAGGGCACGTTGTTCTTCGCCGGCGAGCACTGCTCGACCTACCCGGCGTGGATCGAGGGCGCGATCGAGTCCGGCCTCGCGGCGGCCCAGGACGTCCACGCCGCCGCTCCGGCCGAACGCCCGCTCGTGGCGACCGGGTACCGGCGCATGAGGGGTGGCGCGGCATGA	MWAQGRGGTIPFMSPVHTNVLSGGQHWPQRPKRVTVLGAGVAGLVAAHELERLGHSVEVLEARLEVGGRVRTHSFVGRGPLAELGAMRIPASHHRTMQWIDLLGLSDRVRQFRTLFSDDSSYLETCTGHLRVRDATSVLVEEFRRGLPPGEYREESVLAATWLTASVNAVAPGAFRTNLHSDLNLELLDLLDGIDVRPFFVSTGGVERLDVNRFFAGNPKFAGRSRLAHFFDDITVETSSALFRLEGGMDQITVRLAGSLRGPVHRGRQVVGLHVRPDGVVVETRRGLDVVASHCDYVLCTVPFSVVRRMNLSGLDDDKVATVHDMQYWPATKIAVHCQDAFWEGDGISGGGSFTGGLVRQTYYPPVESDPRLGAALLASYTIGPDSDALTRFSPPERERVVLDELSRIHPELKRPGMVLDVVTQAWGEDFSSMGAASVRWSKDAATAEEERALAAKPQGTLFFAGEHCSTYPAWIEGAIESGLAAAQDVHAAAPAERPLVATGYRRMRGGAA	MTFLFKEFKGVFKMKKVLVVGAGVAGLAVCYWLKEFGFSPTLIEKSNALRKGGYGVDIFGIAVDIAKKMSVYEKICAMRTQLEHGFYVNADGHTLVEEQGEKFGFRQGEEVEILREDLIEILKQAIKDIPCHFNQRIKRIKQDGKHVEVTFKDNKTENYDLVIGADGVHSTTRAFTFDKEEYDLIDFGCYSAIFSLPNYLKLRQSEIAFDANQKFISVSSDKNPTIALASLMFHSNRGDNIRNEKDQKSFFKDAFIDLGWETNNLLQYMEESNDFYFDVATQIKMKSWTKGRIALVGDSGYCSTALSGQGTTTALVGAYILAGELKAANGNHITAFERYNMLLHPFVEANQELGAWINETFLLEDAVSKEAVEARTDNIIKKISAISNVIKLPEYSAYK	128.57	gnl|BL_ORD_ID|2720|hsp_num:0	3284			36	132	tetracycline; oxytetracycline
BGC0001333.1|BE-54017_12 # 14439 # 16040 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.709	BGC0001333.1|BE-54017_12 	14439	16040	+	Loose	550	129.028	Nocardia farcinica rox	29.49	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGAACCCAGTGGAGAACGACGTGCTCGAGACCGAAGTGATCATCGTCGGCGGCGGGCCGACCGGCATGGCCACCGCGCTGGAACTGCGTTCGCGTGGCGTCGACTTCGTCCTGGTCGAGGCCGGCGACGGCACGGTCGGTCATCCCAAGGTGTCCAGCATCGGCCCCCGGTCCATGGAGTTCTTCCGCCGCTGGGGTGTCGCGGACGCCGTTCGCCACTCCGGCTGGCCCGAGGACCACCCGCTCGACTGCGTGTGGACCACCAGGATCGGCGGACACGAGCTCTTCCGCCTCCCCCGCCACACGATGGGCACCAGACCGGACTTCCGGCACACCCCGGAACCGGACGCGATCTGCCCGCAGCACTGGCTCGGTCCGCTGCTGCGCGGGGCTCTGGGCGTCCACCCGGACGGACCGGTGCGGATGAGCACGCGCCTGGAGTCGTTCACGCAGGACGACACCGGCGTTCACGCGGTGCTGAGCGACGGCACCGAGGTGCACGCGCAGTACCTGATCGCCTGCGACGGCGCGAGCTCGCCGATCCGCAAGCACCTCGGCATCGCGGCTCCCGCCGTCCACGACGCGCTGGTCTTCCGCAACGTCCTGTTCCGCGCGCCCGAACTGCGCGAGCGGCTCGGCGACCAGGTCGCCAACTTCTACTACCTCATGATCTCCTCCGCACTGCGCTTCCCCGTCCGCGCGCTGGACGGCCGGGAGCTGTACCGGATGACGGTCGGGCTGCAGGGCTCACCCGAGTCGTTGCAGGAGGCCGAGACCTTGGTGCGCAAGGCGATCGCGTTCGACACGCCGGTGGAGGTGGTGTCCGACAACGAGTGGCACCTGGTGCACCGGGTCGCCGAGGACTTCCGCTCCGGCCGGGTCTTCCTCGTCGGGGACGCCGCGCACACGCTGTCGCCGTCGGGTGGGTTCGGCATGAACACCGGCATCTGCGGCGCCGCGGACCTCGGCTGGAAGCTCGCGGCCGAGCTGCGCGGGTGGGCGGGCCCGGACCTGCTCGACAGCTACACGCGGGAGCGTCAGCCGGTCGCGTTCGAGGGTCTGGAGGAGGCCAACCGCAACCTGGAACGGGCGATGCGCCGCGAGGTGCCGCCGTTCCTGAACGACGACACCGAGCAGGGCGCGGCGATGCGGTCGAAGATCAGCGAAGGGCTCCAGCGCGGCGGCGTGGCCCGCGAGTTCGACGCGCCGGAGATCCACCTCGGTTTCACCTATGCCGGATCGGCGCTGGTCGTCGACGACCCGACGGCGGAGAACCTGCAGGACCGCAGGCCGAACACCCGGCCGGGGTCCCGCGCACCGCACGCGTGGGTGAAGGACGGCCTGTCCACATTGGACCTCTTCGGAGACGGGTTCGTGCTGGTGCACTTCGAGAACTCCGCACGCCTGGCGTCGTTCGCCAAGGCGTTCGAGTCGCGGGGGATTCCGTTCCGCGCGGAGTGCCTGGACTCGCCGGAGATCGCGCACGCCTATGAACGGCCGTTCGTCCTGGTGCGGCCGGACGGGCACGTGGCCTGGCGGGGAACCGAGCTGCCCGCGGACGCAGGGACGATCGCGGACACCGTGCGCGGAGGTGCGCGGTGA	MNPVENDVLETEVIIVGGGPTGMATALELRSRGVDFVLVEAGDGTVGHPKVSSIGPRSMEFFRRWGVADAVRHSGWPEDHPLDCVWTTRIGGHELFRLPRHTMGTRPDFRHTPEPDAICPQHWLGPLLRGALGVHPDGPVRMSTRLESFTQDDTGVHAVLSDGTEVHAQYLIACDGASSPIRKHLGIAAPAVHDALVFRNVLFRAPELRERLGDQVANFYYLMISSALRFPVRALDGRELYRMTVGLQGSPESLQEAETLVRKAIAFDTPVEVVSDNEWHLVHRVAEDFRSGRVFLVGDAAHTLSPSGGFGMNTGICGAADLGWKLAAELRGWAGPDLLDSYTRERQPVAFEGLEEANRNLERAMRREVPPFLNDDTEQGAAMRSKISEGLQRGGVAREFDAPEIHLGFTYAGSALVVDDPTAENLQDRRPNTRPGSRAPHAWVKDGLSTLDLFGDGFVLVHFENSARLASFAKAFESRGIPFRAECLDSPEIAHAYERPFVLVRPDGHVAWRGTELPADAGTIADTVRGGAR	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	112.68	gnl|BL_ORD_ID|4834|hsp_num:0	5821			6	1371	rifampin
BGC0001333.1|BE-54017_13 # 16037 # 16345 # 1 # ID=1_13;partial=01;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.696	BGC0001333.1|BE-54017_13 	16037	16345	+	Loose	550	25.7942	SHV-122	27.27	3001169	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	SHV beta-lactamase	GTGAAGCCGTTCTCCCTGAAGAACTGGACGGACGAGGACCTGCACAACCCCTTCCCGGTGTTCGCCCGCTACCTGGCGAACGGTCCCCTGCACCGCGCCGACGGCACCTGGTACGTGTTCGGCCACGACGCCGCGGTCGAGGTGCTGACCGGTTCCGCCTTCGGCCGCCGCTCGCCGGCGGGCGGCGGGAGCCCCGTGTCGGTGCCGTCGGCATTGCGCACGCTCGTGGAGAACTGGCTGGTCTTCCTCGACCCACCACGGCACACCGAGCTGCGATCGGTGCTGAACAAGGAGTTCTCACCCGCCGTG	MKPFSLKNWTDEDLHNPFPVFARYLANGPLHRADGTWYVFGHDAAVEVLTGSAFGRRSPAGGGSPVSVPSALRTLVENWLVFLDPPRHTELRSVLNKEFSPAV	MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDPPGGTELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR	35.89	gnl|BL_ORD_ID|824|hsp_num:0	895			273	510	
